vs
亚什兰（ASH）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是Bio-Techne的1.3倍（$386.0M vs $295.9M），Bio-Techne净利率更高（12.8% vs -3.1%，领先16.0%），亚什兰同比增速更快（-4.7% vs -6.4%），过去两年Bio-Techne的营收复合增速更高（4.2% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
ASH vs TECH — 直观对比
营收规模更大
ASH
是对方的1.3倍
$295.9M
营收增速更快
ASH
高出1.7%
-6.4%
净利率更高
TECH
高出16.0%
-3.1%
两年增速更快
TECH
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $295.9M |
| 净利润 | $-12.0M | $38.0M |
| 毛利率 | 27.2% | 64.6% |
| 营业利润率 | -1.6% | 18.4% |
| 净利率 | -3.1% | 12.8% |
| 营收同比 | -4.7% | -6.4% |
| 净利润同比 | 92.7% | 68.3% |
| 每股收益（稀释后） | $-0.26 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHTECH
| Q4 25 | $386.0M | $295.9M | ||
| Q3 25 | $477.0M | — | ||
| Q2 25 | $463.0M | $317.0M | ||
| Q1 25 | $479.0M | $316.2M | ||
| Q4 24 | $405.0M | $297.0M | ||
| Q3 24 | $521.0M | $289.5M | ||
| Q2 24 | $544.0M | $306.1M | ||
| Q1 24 | $575.0M | $303.4M |
净利润ASHTECH
| Q4 25 | $-12.0M | $38.0M | ||
| Q3 25 | $31.0M | — | ||
| Q2 25 | $-742.0M | $-17.7M | ||
| Q1 25 | $31.0M | $22.6M | ||
| Q4 24 | $-165.0M | $34.9M | ||
| Q3 24 | $17.0M | $33.6M | ||
| Q2 24 | $6.0M | $40.6M | ||
| Q1 24 | $120.0M | $49.1M |
毛利率ASHTECH
| Q4 25 | 27.2% | 64.6% | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 28.5% | 62.7% | ||
| Q1 25 | 30.7% | 67.9% | ||
| Q4 24 | 27.4% | 65.3% | ||
| Q3 24 | 33.2% | 63.2% | ||
| Q2 24 | 34.2% | 66.4% | ||
| Q1 24 | 28.0% | 67.4% |
营业利润率ASHTECH
| Q4 25 | -1.6% | 18.4% | ||
| Q3 25 | 12.8% | — | ||
| Q2 25 | -152.9% | -7.5% | ||
| Q1 25 | 10.6% | 12.2% | ||
| Q4 24 | -44.2% | 16.0% | ||
| Q3 24 | 6.1% | 13.8% | ||
| Q2 24 | -11.2% | 15.0% | ||
| Q1 24 | 3.7% | 22.1% |
净利率ASHTECH
| Q4 25 | -3.1% | 12.8% | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | -160.3% | -5.6% | ||
| Q1 25 | 6.5% | 7.1% | ||
| Q4 24 | -40.7% | 11.7% | ||
| Q3 24 | 3.3% | 11.6% | ||
| Q2 24 | 1.1% | 13.3% | ||
| Q1 24 | 20.9% | 16.2% |
每股收益（稀释后）ASHTECH
| Q4 25 | $-0.26 | $0.24 | ||
| Q3 25 | $0.83 | — | ||
| Q2 25 | $-16.21 | $-0.11 | ||
| Q1 25 | $0.65 | $0.14 | ||
| Q4 24 | $-3.50 | $0.22 | ||
| Q3 24 | $0.34 | $0.21 | ||
| Q2 24 | $0.12 | $0.26 | ||
| Q1 24 | $2.39 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $172.9M |
| 总债务越低越好 | $1.4B | $260.0M |
| 股东权益账面价值 | $1.9B | $2.0B |
| 总资产 | $4.5B | $2.5B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ASHTECH
| Q4 25 | $304.0M | $172.9M | ||
| Q3 25 | $215.0M | — | ||
| Q2 25 | $207.0M | $162.2M | ||
| Q1 25 | $168.0M | $140.7M | ||
| Q4 24 | $219.0M | $177.5M | ||
| Q3 24 | $300.0M | $187.5M | ||
| Q2 24 | $399.0M | $152.9M | ||
| Q1 24 | $439.0M | $145.3M |
总债务ASHTECH
| Q4 25 | $1.4B | $260.0M | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | $346.0M | ||
| Q1 25 | $1.3B | $330.0M | ||
| Q4 24 | $1.3B | $300.0M | ||
| Q3 24 | $1.3B | $300.0M | ||
| Q2 24 | $1.3B | $319.0M | ||
| Q1 24 | $1.3B | $389.0M |
股东权益ASHTECH
| Q4 25 | $1.9B | $2.0B | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.9B | $1.9B | ||
| Q1 25 | $2.6B | $2.0B | ||
| Q4 24 | $2.6B | $2.1B | ||
| Q3 24 | $2.9B | $2.1B | ||
| Q2 24 | $3.0B | $2.1B | ||
| Q1 24 | $3.1B | $2.0B |
总资产ASHTECH
| Q4 25 | $4.5B | $2.5B | ||
| Q3 25 | $4.6B | — | ||
| Q2 25 | $4.6B | $2.6B | ||
| Q1 25 | $5.2B | $2.6B | ||
| Q4 24 | $5.2B | $2.7B | ||
| Q3 24 | $5.6B | $2.7B | ||
| Q2 24 | $5.7B | $2.7B | ||
| Q1 24 | $5.9B | $2.7B |
负债/权益比ASHTECH
| Q4 25 | 0.74× | 0.13× | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | 0.18× | ||
| Q1 25 | 0.52× | 0.16× | ||
| Q4 24 | 0.51× | 0.14× | ||
| Q3 24 | 0.47× | 0.14× | ||
| Q2 24 | 0.45× | 0.15× | ||
| Q1 24 | 0.42× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | — |
| 自由现金流经营现金流 - 资本支出 | $111.0M | — |
| 自由现金流率自由现金流/营收 | 28.8% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHTECH
| Q4 25 | $125.0M | — | ||
| Q3 25 | $40.0M | — | ||
| Q2 25 | $115.0M | $98.2M | ||
| Q1 25 | $9.0M | $41.1M | ||
| Q4 24 | $-30.0M | $84.3M | ||
| Q3 24 | $80.0M | $63.9M | ||
| Q2 24 | $127.0M | $75.5M | ||
| Q1 24 | $54.0M | $81.0M |
自由现金流ASHTECH
| Q4 25 | $111.0M | — | ||
| Q3 25 | $6.0M | — | ||
| Q2 25 | $95.0M | $93.3M | ||
| Q1 25 | $-12.0M | $31.0M | ||
| Q4 24 | $-53.0M | $77.5M | ||
| Q3 24 | $42.0M | $54.7M | ||
| Q2 24 | $98.0M | $57.5M | ||
| Q1 24 | $20.0M | $64.5M |
自由现金流率ASHTECH
| Q4 25 | 28.8% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 20.5% | 29.4% | ||
| Q1 25 | -2.5% | 9.8% | ||
| Q4 24 | -13.1% | 26.1% | ||
| Q3 24 | 8.1% | 18.9% | ||
| Q2 24 | 18.0% | 18.8% | ||
| Q1 24 | 3.5% | 21.3% |
资本支出强度ASHTECH
| Q4 25 | 3.6% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 4.3% | 1.5% | ||
| Q1 25 | 4.4% | 3.2% | ||
| Q4 24 | 5.7% | 2.3% | ||
| Q3 24 | 7.3% | 3.2% | ||
| Q2 24 | 5.3% | 5.9% | ||
| Q1 24 | 5.9% | 5.4% |
现金转化率ASHTECH
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.29× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | 4.71× | 1.90× | ||
| Q2 24 | 21.17× | 1.86× | ||
| Q1 24 | 0.45× | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
